FDA STATE_REFERRAL_LETTER - Auro Pharmacies, Inc. - August 08, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Auro Pharmacies, Inc.

Record Details

This STATE REFERRAL LETTER record concerns Auro Pharmacies, Inc., with an inspection on August 8, 2022, issued by the Division of Pharmaceutical Quality Operations I, covering drugs.

Company: Auro Pharmacies, Inc.
Inspection Date: August 8, 2022
Product Type: Drugs
Office: Division of Pharmaceutical Quality Operations I
People: Nayan J. Patel (Senior Lead Reviewer and Intercenter Consult Team Leader)
Steven E. Porter (Program Division Director)
Anne Sodegren
Mariza Jafary

Open in Dashboard

ID · c4b4e72d-5026-44a3-8896-fafc83e84153

Violation Codes3

21 CFR 20.64(d)(3)21 CFR 20.88FD&C Act 503A

Full citation text and observation details available on the Dashboard.